Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Seaport Therapeutics, Inc (SPTX) had Stock-Based Compensation of $6.88M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-74.88M |
|
-- |
|
-- |
|
$87.29M |
|
$-87.29M |
|
$13.19M |
|
$-74.11M |
|
$-74.11M |
|
$-74.88M |
|
$-74.88M |
|
$-74.88M |
|
$-74.88M |
|
$-87.29M |
|
$-89.32M |
|
2.37M |
|
2.37M |
|
$-31.54 |
|
$-31.54 |
|
| Balance Sheet Financials | |
$223.23M |
|
$0.41M |
|
$25.78M |
|
$249.01M |
|
$12.78M |
|
-- |
|
$3.44M |
|
$16.23M |
|
$-92.55M |
|
$232.78M |
|
$232.78M |
|
-- |
|
| Cash Flow Statement Financials | |
$-77.94M |
|
$-184.25M |
|
$-0.87M |
|
$309.55M |
|
$46.50M |
|
$-263.06M |
|
|
Stock-Based Compensation |
$6.88M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.46 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-78.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.91% |
|
-32.17% |
|
-30.07% |
|
-32.17% |
|
-- |
|
$-32.98 |
|
$-32.83 |
|